He holds a degree in Medicine and Surgery from the Autonomous University of Barcelona, is a Specialist in Clinical Pharmacology, and a Professor at the UAB.

He has been Chief Clinical Officer of the Hospital del Mar in Barcelona and has subsequently spent his career in important positions in the public sector: He has been director General of the National Plan on Drugs in the Ministry of Health, Undersecretary of the Ministry of Culture, Undersecretary of the Ministry of Social Affairs, and Senior Expert in the General Secretariat of the European Commission. He was also Delegate in Madrid of the Government of the Generalitat de Catalunya. His experience in the private sector has mainly been in the ICT, Health, and Renewable Energy sectors. He has been Vice-President of Terra Lycos, President of Eolia Tarraco, member of the Advisory Board of Indra, promoter of the Telemedicine company eDiagnostic, and member of the board of directors of Mémora.

Santiago de Torres is the founder of Atrys and has served as executive chairman until he was re-elected as a director in the category of other external directors on 12 June 2025 for a period of four years.

As of 31 December 2025, Santiago de Torres directly holds 139,284 shares in Atrys Health, S.A.

She holds a degree in Business and Economics from the University San Pablo CEU, and a master’s degree in Economic and Financial Management from Centro de Estudios Financieros (CEF).

Marian Isach has over 27 years of experience as a managing director in the healthcare sector and over 25 years’ experience in oncology, with a clear focus on business development. She has developed and led organic and inorganic growth strategies at a national level within both the private and public sectors forgoing innovative partnerships. She also has extensive experience of working with multinational companies, both family-owned and privately held, such as Nazca Capital and Nexxus Iberia.

In February 2022, Marian Isach joined Atrys as General Manager of the Oncology Division. In this role, she was responsible for defining and implementing the division’s strategic plan, overseeing the income statement and expanding its activities internationally in Latin America and Europe. She also supervised and led operations across all business area, ensuring operational and financial efficiency.

She has previously held senior positions at various healthcare entitiesincluding Affidea, Candesic and GenesisCare Spain, as well as at consulting firms specialising in defining and implementing strategic plans and business models for public and private companies, and in market analysis, commercial and marketing strategies.

Marian Isach was elected as a director of Atrys on 12 June 2025 for a period of four years.

As of 31 December 2025, she directly holds 118,659 Atrys Health, S.A. shares.

He holds a degree in Economics and Actuarial and Financial Sciences from the University of Barcelona, and a master’s degree in Financial Management from ESADE.

He was CFO of Oryzon Genomics, S.A. from 2003 to 2007.

He is currently CEO of Inveready Asset Management, S.G.E.C.R., S.A. and Chairman of Grupo Financiero Inveready, companies of which he has been a founding partner and major shareholder.

Member of the Board of Directors of more than 30 companies such as Masmóvil Ibercom, S.A., Agile Contents, S.A., Oryzon Genomics, S.A., Interiorvista, S.L., Palo Biofarma, S.L. or Grupo Natac, S.L.

He has actively participated in dozens of corporate transactions such as the sale of Passwordbank Technologies, S.L., the purchase of Pepephone by Masmóvil or the sale of Indisys, S.L. to Intel.

José Mª Echarri was elected as a proprietary director of Atrys, representing Inveready Convertible Finance Capital FCR, on 22 July 2021. He was subsequenlty re-elected on 10 December 2021 and 19 December 2025, meaning his term of office runs until 19 December 2029.

As of 31 December 2025, Jose Mª Echarri directly holds 100 Atrys Health, S.A. shares.

He holds a degree in Law from the Complutense University of Madrid and a master’s degree in Science from the University of Wales, Institute of Science and Technology (UWIST).

Chief Executive Officer and founding partner of Geniova Technologies, a dental company owned by the Swiss multinational Straumann Group.

From 1986 to 1992 he was Vice President of Bankers Trust Company Sucursal en España. From 1992 to 2008 he was founding partner and Managing Director of Bridgepoint Capital in Spain.

Since 2008 he dedicates part of his time to entrepreneurship, promoting and participating as an investor in several consumer companies and technology start-ups. He is also Senior Advisor at Avior, a 100% independent private equity firm focused on investing in Spanish companies.

Antonio Baselga was elected as a proprietary director of Atrys, representing Onchena S.L., on 17 October 2019 and was re-elected on 19 December 2025, meaning his term of office runs until 19 December 2029.

As of 31 December 2025, Antonio Baselga de la Vega directly holds 7,000 Atrys Health, S.A. shares.

Manuel Guerrero Maldonado holds a degree in Economics from the Complutense University of Madrid. He also holds an Executive MBA from the IESE Business School of the University of Navarra.

He has developed his professional career at Deutsche Bank, Barclays Bank (Head of the Restructuring Department), H.I.G. Capital (Director of Bayside Capital Iberia) and Ben Oldman Partners (Managing Director), in the areas of direction, analysis and management of investments, capital markets and debt.

He is currently Chief Investment Officer of Ion Ion.

He was appointed as a proprietary director of Atrys, representing Ion Ion S.L., by the board on 30 January 2023, by co-optation procedure (procedimiento de cooptación) and ratified by the shareholders at the general shareholders’ meeting held on 28 June 2023. His term of office runs until 28 June 2027.

As of 31 December 2025, Manuel Guerrero directly holds 1,587 Atrys Health, S.A. shares.

She holds a degree in Law from the University of Barcelona, a postgraduate degree in Labour Law, and a PDG (General Management Programme) qualification from IESE Business School.

She began her professional career at Grupo Godó in 1995, in the Sales, Finance and finally Controlling departments. Anabel López Porta joined Fersa Energías Renovables in 2004 as Assistant General Manager and participated in its IPO in May 2007. Throughout her career at Fersa she participated in the development of the portfolio of power generation projects as well as in the execution of the divestment plans of these projects, both nationally and internationally.

Appointed Chief Operating Officer in 2011, she was directly involved in all corporate operations of the company and assumed the General Management in July 2015, integrally managing the sale operation of the Fersa group that culminated in a takeover bid process by Audax Energía, S.A. Subsequently, in 2019, he participated directly in the reverse merger operation between Audax Energía and Fersa Energía Renovables, resulting in Grupo Audax Renovables, an independent energy group whose activities are focused on the production of 100% renewable energy, as well as the supply of 100% renewable electricity and gas.

He is currently a member of the board of directors and of the audit, nomination and remuneration committees of Audax Renovables. She is also a member of the board of directors of Ezentis and of its audit committee.

Anabel López was appointed as a proprietary director of Atrys, representing Excelsior Times S.L., on 10 December 2021 and was re-elected on 19 December 2025, meaning his term of office runs until 19 December 2029.

Degree in Industrial Technical Engineering from the Polytechnic University of Cataluña.

He has founded several companies in the energy sector and was a pioneer in the liberalized electricity market.

In 1994 he began his professional career working in the City Council of Rubí, in the area of urban planning and maintenance, in 1996 he joined Control Energético JGC, S.L. and in 1997 he founded his first company dedicated to integral installations. In 2009 he founded Orus Energía, S.L. and was its general manager. In 2012 he acquired the trading company Audax Renovables, of which he has been sole director and CEO.

He is an indirect majority shareholder (through Eléctrica Nuriel, S.L.) of Audax Renovables, S.A. and Chairman of its Board of Directors. He is also sole director and sole shareholder of the financial holding Excelsior Times, S.L., which is the largest shareholder of Ezentis.

Excelsior Times, S.L. was the majority shareholder of Aspy Global Services, S.L. until the acquisition of the latter by Atrys.

He was appointed as a proprietary director of Atrys, representing Excelsior Times S.L., on 28 June 2024, meaning his term of office runs until 28 June 2028.

He holds a degree in Law from the University of Cantabria and has taken several courses at IESE and the New York Institute of Finance.

He served as director of internal audit for the Banco Santander group in the United States. He was manager of the same Bank in Bolivia, director with investors, analysts and investors in New York and executive vice president in Colombia until 2005.

Member since 2015 of the advisory board for LatAm of Howden, advisor to BNP Cardif Mexico, and advisor to El Corte Inglés among others. He is managing partner of Negozia S.A. and Senior Advisor at Coltefinanciera and PMGroup.

Jaime Cano was appointed as an independent director of Atrys on 24 June 2016 and re-elected on 28 June 2022, meaning his term of office runs until 28 June 2026.

She holds a degree in Law from the University of Valladolid and a Master’s degree in European Politics from the College of Bruges and was Senior Associate at St Antony’s College, Oxford.

She began her career holding various positions in the institutional field as an advisor in commercial law and economic relations for the European Union and the British Government. Subsequently, Miriam worked as a partner in several renowned international law firms such as DLA Piper and Dechert LLP. She has also held relevant positions on the boards of national and international listed companies, becoming a director of Acciona; Chair of the Audit and Remuneration Committees of UBS Limited in the UK; Chair of the Audit and Risk Committees of UBS Spain and and Vice-Chair of UBS ESE. She has been an adjunct professor at Stanford University. Miriam is currently founder of España Mejor, Inspiring Girls and Altius (an Africa-focused law firm), a member of the panel of international trade arbitrators of the European Union and a member of the Diversity Council of Toyota Europe, among others.

Miriam González was appointed as an independent director of Atrys on 28 June 2023, meaning her term of office runs until 28 June 2027.

He holds a degree in Law from the Complutense University of Madrid, 1995. LL.M. from Leibniz University Hannover (Germany), 1996; Advanced Programme in
Telecommunications, Media and Information Technology Law, Instituto de Empresa, 2001; American Law Programme, Columbia University, New York, 2009. 

Founding partner of Castañeda Abogados (2002). Secretary of the Board of Directors of numerous companies belonging to Spanish and international groups, including Masmovil Ibercom, the fourth largest telecommunications operator in Spain, Xfera Consumer Finance EFC, Kreab Iberia or Minerals Technologies, he has more than 25 years of experience in advising in the field of corporate law.

Alberto Castañeda was appointed non-director secretary on 17 May 2018.

She holds a degree in Law and Business Administration and Management (ADE) from the Universidad Pontificia de Comillas (ICADE E-3). She holds a master’s degree in International Legal Studies (LL.M) from Georgetown University (Washington DC).

Gabriela is the legal head of the entire Atrys Group. Prior to joining Atrys, she worked in different national and international law firms (Cuatrecasas, Linklaters and Pinsent Masons) specializing in corporate and M&A law.

She joined Atrys in September 2020 and was appointed vice-secretary non-counselor on 27 October 2020.